Linezolid for drug-resistant tuberculosis

Bhagteshwar Singh*, Derek Cocker, Hannah Ryan, Derek J. Sloan

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

62 Citations (Scopus)


This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

To assess the efficacy of linezolid when used as part of a second-line regimen for treating people with multidrug-resistant (MDR-) and extensively drug-resistant (XDR-) pulmonary tuberculosis (TB), and to assess the prevalence and severity of adverse events associated with linezolid use in this patient group.
Original languageEnglish
Article numberCD012836
Pages (from-to)1-9
Number of pages9
JournalCochrane Database of Systematic Reviews
Issue number11
Publication statusPublished - 10 Nov 2017

Cite this